郑州高新国资入主近四年后，老牌中药企业太龙药业或再次“易主”

Core Viewpoint - Tai Long Pharmaceutical, known for its Double Yellow Liquid, is undergoing a potential change in control as its major shareholder, Zhengzhou Tai Rong Industrial Investment Co., is planning to transfer shares, which may lead to a change in the company's ownership structure [1] Group 1: Company Background - Tai Long Pharmaceutical is headquartered in Zhengzhou, Henan, and operates in four main business segments: pharmaceutical formulations, traditional Chinese medicine pieces, drug research and development services, and pharmaceutical material circulation [1] - The company’s unique products include the Double Yellow Liquid and Pediatric Compound Chicken Inner Gold Chewable Tablets [1] - Tai Long Pharmaceutical became a significant platform for promoting the biopharmaceutical and health industry in the region after Tai Rong Investment became its controlling shareholder in early 2022 [1][2] Group 2: Shareholder Changes - On November 29, 2021, Tai Rong Investment signed a share transfer agreement to acquire 82,441,168 shares from the previous controlling shareholder, Zhengzhou Zhongsheng Industrial Group, representing 14.37% of the total share capital [2] - Prior to this transfer, the actual controller of Tai Long Pharmaceutical was the People's Government of Zhu Lin Town, Gongyi City, Henan Province [2] - The change in controlling shareholder was aimed at enhancing the company's strategic development in traditional Chinese medicine and health sectors [2] Group 3: Financial Performance - After Tai Rong Investment took control, Tai Long Pharmaceutical reported a significant decline in net profit, with a year-on-year decrease of 1303.26%, resulting in a loss of 72.2 million yuan in 2022 [3] - In 2023, the company showed improvement with total revenue reaching 2.07 billion yuan, marking a historical high, and a net profit of 43.56 million yuan [3] - For the first three quarters of 2025, the company reported revenue of 1.187 billion yuan, a year-on-year decline of 11.47%, and a net profit of 25.33 million yuan, down 12.36% [4]